Forbes contributors publish independent expert analyses and insights. Kate O’Flaherty is a cybersecurity and privacy journalist.

Human resources giant Workday has disclosed a data breach after attackers gained access to a third-party customer relationship management (CRM) platform in a recent social engineering attack.

Danish jewelry giant Pandora has disclosed a data breach after its customer information was stolen in the ongoing Salesforce data theft attacks. Pandora is one of the largest jewellery brands in the ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Generating longitudinal and multi-layered big ...

Trump accused the Bureau of Labor Statistics commissioner of erroneously reporting jobs data after it made a massive downward revision for May and June numbers. Photo by Anna Moneymaker/Getty Images ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› We independently review everything we recommend. When you buy through our links, ...

Endogenex today reported positive findings from studies of its endoscopic procedure aimed at transforming diabetes care. Minneapolis-based Endogenex shared findings in poster presentations at the ...

MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), will present results from ...

Evaluating the cost-effectiveness of genetic testing in high-risk families with confirmed germline cancer mutations. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) just the other day announced that it had achieved the primary endpoint of its pivotal phase 3 ROSELLA study. This late-stage study tested the company's ...

(RTTNews) - Zentalis Pharmaceuticals Inc. (ZNTL) announced updated clinical data from Part 1b of the ongoing DENALI clinical trial of azenosertib in patients with platinum-resistant ovarian cancer or ...